Status:
NOT_YET_RECRUITING
In-Depth Characterisation of Biliary Strictures and Hepato-Pancreato-Biliary Focal Lesions for Development of New Technologies to Tackle Hepato-Pancreato-Biliary Cancers
Lead Sponsor:
University of Nottingham
Conditions:
Biliary Tract Cancer (BTC)
Biliary Tract Cancer (CCA)
Eligibility:
All Genders
16+ years
Brief Summary
Hepato-Pancreato-Biliary (HPB) cancers originating in the liver, bile ducts, pancreas, and gall bladder represent a rising global health challenge, with incidence doubling in the UK over the past deca...
Eligibility Criteria
Inclusion
- Aged 16 years and over
- Ability to provide informed consent to participate in the study
- Patients attending Nottingham University Hospitals NHS Trust (NUH) as part of standard clinical care for either:
- the diagnosis and treatment of suspected biliary stricture or any focal lesion in the Hepato-Pancreato-Biliary (HPB) tract (clinically / radiologically) including liver or pancreatic lesion or pancreatic cyst
- surgical resection treatment of liver, pancreas, or gall bladder including Whipple Procedure (pancreaticoduodenectomy surgery), gall bladder resection (cholecystectomy), hepatic resection
Exclusion
- No exclusion criteria
Key Trial Info
Start Date :
October 1 2025
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
September 30 2030
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT07206355
Start Date
October 1 2025
End Date
September 30 2030
Last Update
October 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Nottingham
Nottingham, United Kingdom